SEMA6D expression and patient survival in breast invasive carcinoma

International Journal of Breast Cancer

Volumn 2015, Issue , 2015, Pages

  Chen, Dongquan ^a   Li, Yufeng ^a   Wang, Lizhong ^a,b   Jiao, Kai ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CYTOKERATIN 19; CYTOKERATIN 7; DESMOCOLLIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GELATINASE B; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; PLEXIN; PROGESTERONE RECEPTOR; SEMAPHORIN; SEMAPHORIN 6D; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C;

ARTICLE; BREAST CANCER; BREAST INVASIVE CARCINOMA; CANCER SURVIVAL; CELL ADHESION; CELL INTERACTION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER;

EID: 84961741457     PISSN: 20903170     EISSN: 20903189     Source Type: Journal    
DOI: 10.1155/2015/539721     Document Type: Article

References (55)

1. C. Desantis, R. Siegel, P. Bandi, and A. Jemal, "Breast cancer statistics, 2011, " CA: Cancer Journal for Clinicians, vol. 61, no. 6, pp. 409-418, 2011.
2. C. DeSantis, J.Ma, L. Bryan, and A. Jemal, "Breast cancer statistics, 2013, " CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 52-62, 2014.
3. J. Ferlay, D. M. Parkin, and E. Steliarova-Foucher, "Estimates of cancer incidence and mortality in Europe in 2008, " European Journal of Cancer, vol. 46, no. 4, pp. 765-781, 2010.
4. F. Lalloo and D. G. Evans, "Familial breast cancer, " Clinical Genetics, vol. 82, no. 2, pp. 105-114, 2012.
5. M. Bendre, D. Gaddy, R. W. Nicholas, and L. J. Suva, "Breast cancer metastasis to bone: it is not all about PTHrP, " Clinical Orthopaedics and Related Research, no. 415, pp. S39-S45, 2003.
6. A. J. Redig and S. S. McAllister, "Breast cancer as a systemic disease: a view of metastasis, " Journal of Internal Medicine, vol. 274, pp. 113-126, 2013.
7. O. J. Scully, B.-H. Bay, G. Yip, and Y. Yu, "Breast cancer metastasis, " Cancer Genomics & Proteomics, vol. 9, no. 5, pp. 311-320, 2012.
8. S. Byler, S. Goldgar, S. Heerboth et al., "Genetic and epigenetic aspects of breast cancer progression and therapy, " Anticancer Research, vol. 34, no. 3, pp. 1071-1077, 2014.
9. M. A. Blanco andY.Kang, "Signaling pathways in breast cancer metastasis-novel insights from functional genomics, " Breast Cancer Research, vol. 13, no. 2, p. 206, 2011.
10. J. Izrailit and M. Reedijk, "Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications, " Cancer Letters, vol. 317, no. 2, pp. 115-126, 2012.
11. R. J. Pasterkamp, "Getting neural circuits into shape with semaphorins, " Nature Reviews Neuroscience, vol. 13, no. 9, pp. 605-618, 2012.
12. B. P.O'Connor, S.-Y. Eun, Z. Ye et al., "Semaphorin 6D regulates the late phase ofCD4+ T cell primary immune responses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13015-13020, 2008.
13. J. R. Leslie, F. Imai, K. Fukuhara et al., "Ectopic myelinating oligodendrocytes in the dorsal spinal cord as a consequence of altered semaphorin 6D signaling inhibit synapse formation, " Development, vol. 138, no. 18, pp. 4085-4095, 2011.
14. L. Tamagnone, "Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer, " Cancer Cell, vol. 22, no. 2, pp. 145-152, 2012.
15. M. Rehman and L. Tamagnone, "Semaphorins in cancer: biological mechanisms and therapeutic approaches, " Seminars in Cell & Developmental Biology, vol. 24, no. 3, pp. 179-189, 2013.
16. C. Gu and E. Giraudo, "The role of semaphorins and their receptors in vascular development and cancer, " Experimental Cell Research, vol. 319, no. 9, pp. 1306-1316, 2013.
17. G. C. Harburg and L. Hinck, "Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes, " Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 3, pp. 257-270, 2011.
18. U. Yazdani and J. R. Terman, "The semaphorins, " Genome Biology, vol. 7, no. 3, article 211, 2006.
19. T. S. Tran, A. L. Kolodkin, and R. Bharadwaj, "Semaphorin regulation of cellular morphology, " Annual Review of Cell and Developmental Biology, vol. 23, pp. 263-292, 2007.
20. A. Casazza, P. Fazzari, and L. Tamagnone, "Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms, " Advances in Experimental Medicine and Biology, vol. 600, pp. 90-108, 2007.
21. R. P. Kruger, J. Aurandt, and K.-L. Guan, "Semaphorins command cells tomove, " Nature ReviewsMolecular Cell Biology, vol. 6, no. 10, pp. 789-800, 2005.
22. E.Gherardi, C. A. Love, R.M.Esnouf, andE.Y. Jones, "The sema domain, "CurrentOpinion in Structural Biology, vol. 14, no. 6, pp. 669-678, 2004.
23. L. Tamagnone and P. M. Comoglio, "To move or not to move? Semaphorin signalling in cell migration, " EMBO Reports, vol. 5, no. 4, pp. 356-361, 2004.
24. A. Ahmed and B. J. Eickholt, "Intracellular kinases in semaphorin signaling, " Advances in Experimental Medicine and Biology, vol. 600, pp. 24-37, 2007.
25. T. Toyofuku and H. Kikutani, "Semaphorin signaling during cardiac development, " Advances in Experimental Medicine and Biology, vol. 600, pp. 109-117, 2007.
26. T. Toyofuku, H. Zhang, A. Kumanogoh et al., "Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2, " Genes and Development, vol. 18, no. 4, pp. 435-447, 2004.
27. T. Toyofuku, H. Zhang, A. Kumanogoh et al., "Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling, " Nature Cell Biology, vol. 6, no. 12, pp. 1204-1211, 2004.
28. R. L. Matsuoka, L. O. Sun, K.-I. Katayama, Y. Yoshida, and A. L. Kolodkin, "Sema6B, Sema6C, and Sema6D expression and function during mammalian retinal development, " PLoS ONE, vol. 8, no. 4, Article ID e63207, 2013.
29. M. Kimura, M. Taniguchi, Y. Mikami et al., "Identification and characterization of zebrafish semaphorin 6D, " Biochemical and Biophysical Research Communications, vol. 363, no. 3, pp. 762-768, 2007.
30. A. Catalano, R. Lazzarini, S. D. Nuzzo, S. Orciari, and A. Procopio, "Theplexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells, " Cancer Research, vol. 69, no. 4, pp. 1485-1493, 2009.
31. S. Majumder, M. P. Sowden, S. A. Gerber et al., "G-proteincoupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 2, pp. 419-426, 2014.
32. H.-Y. Li, X.-Y.Cui, W.Wu et al., "Pyk2 and Srcmediate signaling to CCL18-induced breast cancer metastasis, " Journal of Cellular Biochemistry, vol. 115, no. 3, pp. 596-603, 2014.
33. S.-H. Chan, W.-C. Huang, J.-W. Chang et al., "MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis, " Oncogene, vol. 33, pp. 4496-4507, 2014.
34. W. Wei, Z.-J. Chen, K.-S. Zhang et al., "The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo, " Cell Death & Disease, vol. 5, Article ID e1428, 2014.
35. J.-M. Renoir, V. Marsaud, and G. Lazennec, "Estrogen receptor signaling as a target for novel breast cancer therapeutics, " Biochemical Pharmacology, vol. 85, no. 4, pp. 449-465, 2013.
36. N. Dey, B. R. Smith, and B. Leyland-Jones, "Targeting basal-like breast cancers, " Current Drug Targets, vol. 13, no. 12, pp. 1510-1524, 2012.
37. J.-M. Renoir, "Estradiol receptors in breast cancer cells: associated co-factors as targets for new therapeutic approaches, " Steroids, vol. 77, no. 12, pp. 1249-1261, 2012.
38. H. Laübli and L. Borsig, "Selectins promote tumor metastasis, " Seminars in Cancer Biology, vol. 20, no. 3, pp. 169-177, 2010.
39. L. Tamagnone, S. Artigiani, H. Chen et al., "Plexins are a large family of receptors for transmembrane, secreted, and GPIanchored semaphorins in vertebrates, " Cell, vol. 99, no. 1, pp. 71-80, 1999.
40. M. Yamamoto, K. Suzuki, T. Okuno et al., "Plexin-A4 negatively regulates T lymphocyte responses, " International Immunology, vol. 20, no. 3, pp. 413-420, 2008.
41. J. Yang, T. Li, C. Gao et al., "FOXO1 3UTRfunctions as a ceRNA in repressing themetastases of breast cancer cells via regulating miRNA activity, " FEBS Letters, vol. 588, no. 17, pp. 3218-3224, 2014.
42. X. Wang, C. Lin, X. Zhao et al., "Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor, " Molecular Cancer, vol. 13, article 106, 2014.
43. X. Feng, Z. Wu, Y. Wu et al., "Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells, " Molecular and Cellular Biology, vol. 31, no. 16, pp. 3457-3471, 2011.
44. D. V. Skarra, D. J. Arriola, C. A. Benson, and V. G. Thackray, "Forkhead box O1 is a repressor of basal and GnRH-induced Fshb transcription in gonadotropes, " Molecular Endocrinology, vol. 27, no. 11, pp. 1825-1839, 2013.
45. O. Mendes, H.-T. Kim, and G. Stoica, "Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model, " Clinical and Experimental Metastasis, vol. 22, no. 3, pp. 237-246, 2005.
46. K. C. Nannuru, M. Futakuchi, M. L. Varney, T. M. Vincent, E. G. Marcusson, and R. K. Singh, "Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor- signaling at the tumor-bone interface, " Cancer Research, vol. 70, no. 9, pp. 3494-3504, 2010.
47. H.E.Barker, J. Chang, T. R. Cox et al., "LOXL2-mediatedmatrix remodeling in metastasis and mammary gland involution, " Cancer Research, vol. 71, no. 5, pp. 1561-1572, 2011.
48. N. K. Nickerson, K. S. Mohammad, J. L. Gilmore et al., "Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad, " PLoS ONE, vol. 7, no. 1, Article ID e30255, 2012.
49. L. Bakiri, S. Macho-Maschler, I. Custic et al., "Fra-1/AP-1 induces EMTinmammary epithelial cells bymodulating Zeb1/2 and TGF expression, " Cell Death&Differentiation, vol. 22, pp. 336-350, 2015.
50. A.Henke, O. C. Grace, G. R. Ashley et al., "Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer, " PLoS ONE, vol. 7, Article IDe42516, 2012.
51. J.W. Lee, J. Lee, and E. Y. Moon, "HeLa human cervical cancer cell migration is inhibited by treatment with dibutyryl-cAMP, " Anticancer Research, vol. 34, no. 7, pp. 3447-3455, 2014.
52. S. D. Kim, Y. J. Lee, J. S. Baik et al., "Baicalein inhibits agonistand tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation, " Biochemical Pharmacology, vol. 92, no. 2, pp. 251-265, 2014.
53. S. Tao, H. He, Q. Chen, andW. Yue, "GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer, " Biochemical and Biophysical Research Communications, vol. 451, no. 1, pp. 74-78, 2014.
54. C. Strell, K. Lang, B. Niggemann, K. S. Zaenker, and F. Entschladen, "Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction, " Cellular and Molecular Life Sciences, vol. 64, no. 24, pp. 3306-3316, 2007.
55. I.A.Mayer, V.G.Abramson, B.D. Lehmann, and J. A. Pietenpol, "New strategies for triple-negative breast cancer-deciphering the heterogeneity, " Clinical Cancer Research, vol. 20, no. 4, pp. 782-790, 2014.